<?xml version="1.0" encoding="UTF-8"?>
<ref id="B109-biomedicines-08-00060">
 <label>109.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Prestwich</surname>
    <given-names>R.J.</given-names>
   </name>
   <name>
    <surname>Harrington</surname>
    <given-names>K.J.</given-names>
   </name>
   <name>
    <surname>Pandha</surname>
    <given-names>H.S.</given-names>
   </name>
   <name>
    <surname>Vile</surname>
    <given-names>R.G.</given-names>
   </name>
   <name>
    <surname>Melcher</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>Errington</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Oncolytic viruses: A novel form of immunotherapy</article-title>
  <source>Expert Rev. Anticancer Ther.</source>
  <year>2008</year>
  <volume>8</volume>
  <fpage>1581</fpage>
  <lpage>1588</lpage>
  <pub-id pub-id-type="doi">10.1586/14737140.8.10.1581</pub-id>
  <pub-id pub-id-type="pmid">18925850</pub-id>
 </element-citation>
</ref>
